Clinical Trial Update: Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sequential IV/PO moxifloxacin with IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in complicated skin and soft ti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Soft Tissue Infection
• Diabetic Foot Infection
• Diabetic Foot Ulcer
• Skin Abscess
• Wound Infection

Drugs mentioned

• Amoxicillin/clavulanic acid (amoxicillin/clavulanic acid)
• Moxifloxacin (moxifloxacin)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Bayer | Conditions: Abscess, Wound Infection | Phase 3 | Status: COMPLETED | Results posted: 2010-01-11